Financial News
Faron Pharmaceuticals CMO "looking forward to a year filled with good data for the patients"
February 16, 2023 at 07:10 AM EST
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
--News Direct--
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief medical officer Marie-Louise Fjällskog updates Proactive's Thomas Warner the clinical-stage biopharmaceutical company's wholly-owned precision immunotherapy asset, Bexmarilimab.
Fjällskog says that she's "looking forward to a year filled with good data for the patients."
Contact Details
Proactive UK Ltd
Proactive UK Ltd
+44 20 7989 0813
View source version on newsdirect.com: https://newsdirect.com/news/faron-pharmaceuticals-cmo-looking-forward-to-a-year-filled-with-good-data-for-the-patients-393299269
Report this content
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this articleMore News
View More
Foresight Solar H1 Earnings Call Highlights ↗
Today 11:02 EDT
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
